missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human Butyrylcholinesterase (aa 199-323) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (78%), Rat (78%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.
Specifications
Specifications
| Accession Number | P06276 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 590 |
| Name | Human Butyrylcholinesterase (aa 199-323) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | acylcholine acylhydrolase; BCHE; BtChE; butylcholinesterase; butyrylcholine esterase; butyrylcholinesterase; C730038G20Rik; CHE1; CHE2; Choline esterase II; cholinesterase; cholinesterase (serum) 2; cholinesterase 1; E1; EC 3.1.1.8; pseudocholinesterase |
| Common Name | Butyrylcholinesterase |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction